Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0140-6736(99)02423-x | DOI Listing |
Publication Analysis
Top Keywords
anomalies 1000
8
congenital anomalies
4
anomalies prenatal
4
prenatal ecstasy
4
ecstasy exposure
4
exposure prospective
4
prospective follow-up
4
follow-up 136
4
136 babies
4
babies exposed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!